what lands in your inbox each week:
- 📚7 fresh studies
- 📝plain-language summaries
- ✅direct links to original studies
- 🏅top journal indicators
- 📅weekly delivery
- 🧘♂️always free
some of our latest newsletters:
(select one to read it below)
CRISPR gene therapy eliminates blood transfusions in 91% of β-thalassemia patients
CRISPR is moving from lab bench to hospital bedside faster than anyone expected. This week brought major advances in treating genetic blood disorders, supercharging crop breeding, and even brewing better whisky.
🩸 CRISPR therapy frees β-thalassemia patients from lifelong transfusions
- 91% of β-thalassemia patients (51 of 56) achieved transfusion independence after receiving exagamglogene autotemcel (exa-cel), a one-time CRISPR gene therapy that reactivates fetal hemoglobin production
- 98% of participants (55 of 56) had been transfusion-free for at least 12 months, with 68% (38 patients) able to stop iron removal therapy entirely after an average of 19.4 months
- The therapy corrected ineffective red blood cell production and restored normal iron balance—key markers that normalized included hepcidin levels and erythroferrone concentrations
Why it matters: This represents a functional cure for a severe genetic blood disorder that typically requires lifelong weekly transfusions. The therapy addresses not just the symptoms but the underlying cellular defects that cause the disease.
Key Findings
🌾 Soybean gene editing reaches 81% efficiency with new prime editor
- Scientists developed GmPEplus, an optimized prime editing system that achieved up to 81.3% editing efficiency in stable soybean lines—a major leap for plant genome editing
- The system can simultaneously edit 2-12 genes in soybean root cultures and up to 3 genes in stable transgenic plants using a multiplex approach
- Key improvements included deleting the RNase H domain, adding viral proteins, and co-expressing a modified version of the plant's own DNA repair gene
🎯 New base editors achieve near-perfect precision without DNA damage
- Researchers combined SpRY (a near-PAM-less Cas9) with truncated deaminases to edit virtually any cytosine in the genome with minimal off-target effects
- Adding HMGN1 and VP64 proteins boosted editing efficiency without compromising precision, working effectively in both yeast and rice
- The system overcomes two major limitations: the need for specific PAM sequences near target sites and unwanted bystander editing of nearby bases
🧠 Non-viral CRISPR corrects hemophilia B in mice using lipid nanoparticles
- Lipid nanoparticles delivered base editor mRNA to correct specific hemophilia B mutations in mice, achieving 35.9-70.6% correction rates depending on the mutation
- The treatment restored blood clotting factor IX activity without using viral vectors, avoiding immune responses and re-dosing limitations of current gene therapies
- Six different nonsense mutations were successfully corrected in cell culture, demonstrating personalized treatment potential
🔍 AI-enhanced CRISPR diagnostics detect Alzheimer's markers with 10,000x sensitivity
- A new detection platform simultaneously measured six Alzheimer's biomarkers (including amyloid-β and phosphorylated tau) with a detection limit of 1 fg/mL—10,000 times more sensitive than standard ELISA tests
- Machine learning integration of the six biomarkers significantly outperformed single-biomarker approaches in diagnosing Alzheimer's disease and mild cognitive impairment in 155 plasma samples
- The system combines antibody-based amplification with CRISPR-Cas12a detection for ultrasensitive protein measurement
🍺 Gene-edited yeast boosts whisky's rose-like aroma by 23%
- CRISPR deletion of the ARO8 gene in Saccharomyces cerevisiae increased 2-phenylethanol (the compound responsible for rose-like aromas) from 0.59 g/L to 0.73 g/L in whisky
- Optimizing fermentation conditions further boosted 2-phenylethanol to 3.68 g/L—more than 6 times the original level
- The modification enhanced flavor without affecting yeast viability or other fermentation characteristics
🩺 CRISPR screen reveals new drug target for liver iron overload
- Base editing corrected the C282Y mutation causing hereditary hemochromatosis in up to 67% of mouse liver cells and 63.8% of patient-derived cells
- Treated mice showed significantly reduced liver iron accumulation and decreased fibrosis markers despite continued high-iron diets
- No off-target effects were detected at genomic sites with one or two DNA mismatches, suggesting a favorable safety profile
Implications
CRISPR technology is rapidly maturing from experimental tool to clinical reality, with successful treatments now eliminating the need for lifelong medical interventions in genetic diseases. The expansion beyond human medicine into agriculture, diagnostics, and even food production suggests we're entering an era where precise genetic modifications could become routine across many industries.
Science is the only real news.
The rest is just drama 📰
And nowadays, we see that drama everywhere.
Drama sells ads, ads sell products, and my attention sells to the highest bidder.
Drama media is junk food for the mind.
A quick rush, hard to avoid, but little nutritional value.
The brain wants broccoli 🧠🥦
And look, it's not that science never makes the news.
But think about when it does—does the news really understand the science it reports on?
Like it or not, AI exists now.
And it happens to be a huge science nerd… 🔭🤖
…with a superpower…
...unlike an average science nerd, AI can explain it simply.
I built OpenScience to make the constant stream of new studies accessible to anyone.
To free science from academic jargon and tiny-fonted PDFs.
OpenScience is a weekly newsletter of 7 compelling studies from the past week in the topic of your choice.
Made simple, digestible, and delightful by AI.
Interested in CRISPR?
The latest Long Covid research?
Psychedelic medicine?
Follow the actual science, as it comes out.
Every study is linked to the original PubMed so you can verify the AI's summary yourself.
Pick a topic, get the weekly email, and give your mind the broccoli it deserves 🥦
The real-time unfolding of science is too interesting not to follow.